On the other hand, we speculate that AKT-mediated PGC-1α inhibition and the subsequent inactivation of metabolic gene transcription are more effectively exerted by skin melanoma cells to counteract mTOR-inhibited PGC-1α degradation upon UA-induced IGF-1 receptor signaling (Figure 3). This evidence concerns the gene PPARGC1A and cutaneous melanoma.